{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:26:28Z","timestamp":1790519188492,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Heidenreich von-Siebold Programm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1197-2","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T11:17:49Z","timestamp":1471000669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation"],"prefix":"10.1186","volume":"17","author":[{"given":"S.","family":"Patschan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Herink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zeisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt F, O\u2019Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet Lond Engl. 2013;382:797\u2013808.","journal-title":"Lancet Lond Engl"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65:1953\u201362.","journal-title":"Arthritis Rheum"},{"key":"1197_CR3","first-page":"573","volume":"1","author":"A Mowat","year":"1972","unstructured":"Mowat A. Connective tissue diseases. Clin Haematol. 1972;1:573\u201394.","journal-title":"Clin Haematol"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2217\/imt.10.69","volume":"2","author":"R Manno","year":"2010","unstructured":"Manno R, Boin F. Immunotherapy of systemic sclerosis. Immunotherapy. 2010;2:863\u201378.","journal-title":"Immunotherapy"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964\u20137.","journal-title":"Science"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.exphem.2007.04.002","volume":"35","author":"J Case","year":"2007","unstructured":"Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, et al. Human CD34\u2009+\u2009AC133\u2009+\u2009VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109\u201318.","journal-title":"Exp Hematol"},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","volume":"109","author":"MC Yoder","year":"2007","unstructured":"Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals. Blood. 2007;109:1801\u20139.","journal-title":"Blood"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1871529X1401140724093505","volume":"14","author":"DP Basile","year":"2014","unstructured":"Basile DP, Yoder MC. Renal endothelial dysfunction in acute kidney ischemia reperfusion injury. Cardiovasc Hematol Disord Drug Targets. 2014;14:3\u201314.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"1197_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050105","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Chen J, Chen S, Zhang C, Zhang L, Xiao X, et al. Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db\/db diabetic mice. PLoS One. 2012;7, e50105.","journal-title":"PLoS One"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/brb3.175","volume":"3","author":"J Mart\u00ed-F\u00e0bregas","year":"2013","unstructured":"Mart\u00ed-F\u00e0bregas J, Crespo J, Delgado-Mederos R, Mart\u00ednez-Ram\u00edrez S, Pe\u00f1a E, Mar\u00edn R, et al. Endothelial progenitor cells in acute ischemic stroke. Brain Behav. 2013;3:649\u201355.","journal-title":"Brain Behav"},{"key":"1197_CR11","doi-asserted-by":"publisher","first-page":"715049\u201312","DOI":"10.1155\/2012\/715049","volume":"2012","author":"S Patschan","year":"2012","unstructured":"Patschan S, Patschan D, Henze E, Blaschke S, Wessels JT, M\u00fcller G-A. Impairment and differential expression of PR3 and MPO on peripheral myelomonocytic cells with endothelial properties in granulomatosis with polyangiitis. Int J Nephrol. 2012;2012:715049\u201312.","journal-title":"Int J Nephrol"},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cns.12040","volume":"19","author":"YH Zhao","year":"2013","unstructured":"Zhao YH, Yuan B, Chen J, Feng DH, Zhao B, Qin C, et al. Endothelial progenitor cells: therapeutic perspective for ischemic stroke. CNS Neurosci Ther. 2013;19:67\u201375.","journal-title":"CNS Neurosci Ther"},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/cc10100","volume":"15","author":"SA Patschan","year":"2011","unstructured":"Patschan SA, Patschan D, Temme J, Korsten P, Wessels JT, Koziolek M, et al. Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Crit Care Lond Engl. 2011;15:R94.","journal-title":"Crit Care Lond Engl"},{"key":"1197_CR14","first-page":"60","volume":"25","author":"Y Allanore","year":"2007","unstructured":"Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A. Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol. 2007;25:60\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1197_CR15","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.22035","volume":"54","author":"N Papa Del","year":"2006","unstructured":"Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006;54:2605\u201315.","journal-title":"Arthritis Rheum"},{"key":"1197_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/ard.2008.091918","volume":"68","author":"JHW Distler","year":"2009","unstructured":"Distler JHW, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR scleroderma trials and research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis. 2009;68:163\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.111.243386","volume":"110","author":"GP Fadini","year":"2012","unstructured":"Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012;110:624\u201337.","journal-title":"Circ Res"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jca.20208","volume":"24","author":"D Patschan","year":"2009","unstructured":"Patschan D, Patschan S, Henze E, Wessels JT, Koziolek M, M\u00fcller GA. LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence. J Clin Apheresis. 2009;24:180\u20135.","journal-title":"J Clin Apheresis"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5301\/jn.5000273","volume":"26","author":"S Patschan","year":"2013","unstructured":"Patschan S, Patschan D, Potulski M, Henze E, Scholze J, M\u00fcller G-A. Endothelial progenitor cells in systemic lupus erythematosus. J Nephrol. 2013;26:1065\u201372.","journal-title":"J Nephrol"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"1197_CR21","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573\u20136.","journal-title":"J Rheumatol"},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/03009742.2014.926985","volume":"43","author":"S Patschan","year":"2014","unstructured":"Patschan S, Nemirovsky K, Henze E, Scholze J, M\u00fcller GA, Patschan D. Tocilizumab increases EPC regeneration in rheumatoid arthritis. Scand J Rheumatol. 2014;43:528\u201330.","journal-title":"Scand J Rheumatol"},{"key":"1197_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2013101137","volume":"26","author":"S Xavier","year":"2015","unstructured":"Xavier S, Vasko R, Matsumoto K, Zullo JA, Chen R, Maizel J, et al. Curtailing endothelial TGF-\u03b2 signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol JASN. 2015;26:817\u201329.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1197_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003;9:964\u20138.","journal-title":"Nat Med"},{"key":"1197_CR25","doi-asserted-by":"publisher","first-page":"835948","DOI":"10.1155\/2013\/835948","volume":"2013","author":"SA Jimenez","year":"2013","unstructured":"Jimenez SA. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013;2013:835948.","journal-title":"ISRN Rheumatol"},{"key":"1197_CR26","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2186","volume":"9 Suppl 2","author":"D Abraham","year":"2007","unstructured":"Abraham D, Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther. 2007;9 Suppl 2:S2.","journal-title":"Arthritis Res. Ther."},{"key":"1197_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rdc.2007.12.004","volume":"34","author":"B Kahaleh","year":"2008","unstructured":"Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am. 2008;34:57\u201371. vi.","journal-title":"Rheum Dis Clin North Am"},{"key":"1197_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/08916930903002487","volume":"42","author":"U M\u00fcller-Ladner","year":"2009","unstructured":"M\u00fcller-Ladner U, Distler O, Ibba-Manneschi L, Neumann E, Gay S. Mechanisms of vascular damage in systemic sclerosis. Autoimmunity. 2009;42:587\u201395.","journal-title":"Autoimmunity"},{"key":"1197_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","volume":"42","author":"M Neidhart","year":"1999","unstructured":"Neidhart M, Kuchen S, Distler O, Br\u00fchlmann P, Michel BA, Gay RE, et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum. 1999;42:389\u201392.","journal-title":"Arthritis Rheum"},{"key":"1197_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/1529-0131(199801)41:1<10::AID-ART2>3.0.CO;2-P","volume":"41","author":"JP Pandey","year":"1998","unstructured":"Pandey JP, LeRoy EC. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum. 1998;41:10\u20135.","journal-title":"Arthritis Rheum"},{"key":"1197_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/08916930109008045","volume":"33","author":"Y Renaudineau","year":"2001","unstructured":"Renaudineau Y, Grunebaum E, Krause I, Praprotnik S, Revelen R, Youinou P, et al. Anti-endothelial cell antibodies (AECA) in systemic sclerosis--increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity. 2001;33:171\u20139.","journal-title":"Autoimmunity"},{"key":"1197_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","volume":"6","author":"M Trojanowska","year":"2010","unstructured":"Trojanowska M. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol. 2010;6:453\u201360.","journal-title":"Nat Rev Rheumatol"},{"key":"1197_CR33","doi-asserted-by":"publisher","first-page":"H285","DOI":"10.1152\/ajpheart.00560.2006","volume":"292","author":"E O\u00b4Riordan","year":"2007","unstructured":"O\u00b4Riordan E, Mendelev N, Patschan S, Patschan D, Eskander J, Cohen-Gould L, et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am J Physiol Heart Circ Physiol. 2007;292:H285\u201394.","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"1197_CR34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952\u201361.","journal-title":"Nat Med"},{"key":"1197_CR35","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol JASN. 2008;19:2282\u20137.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1197_CR36","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/ard.2011.150607","volume":"70","author":"S Guiducci","year":"2011","unstructured":"Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, et al. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis. 2011;70:2011\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1197_CR37","first-page":"831","volume":"22","author":"S Stoelting","year":"2008","unstructured":"Stoelting S, Trefzer T, Kisro J, Steinke A, Wagner T, Peters SO. Low-dose oral metronomic chemotherapy prevents mobilization of endothelial progenitor cells into the blood of cancer patients. Vivo Athens Greece. 2008;22:831\u20136.","journal-title":"Vivo Athens Greece"},{"key":"1197_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3899\/jrheum.131284","volume":"41","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, et al. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J Rheumatol. 2014;41:881\u20136.","journal-title":"J Rheumatol"},{"key":"1197_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4081\/reumatismo.2013.691","volume":"65","author":"S Parisi","year":"2013","unstructured":"Parisi S, Bruzzone M, Centanaro Di Vittorio C, Lagan\u00e0 A, Peroni CL, Fusaro E. Efficacy of bosentan in the treatment of Raynaud\u2019s phenomenon in patients with systemic sclerosis never treated with prostanoids. Reumatismo. 2013;65:286\u201391.","journal-title":"Reumatismo"},{"key":"1197_CR40","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar4457","volume":"16","author":"A Kill","year":"2014","unstructured":"Kill A, Tabeling C, Undeutsch R, K\u00fchl AA, G\u00fcnther J, Radic M, et al. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther. 2014;16:R29.","journal-title":"Arthritis Res Ther"},{"key":"1197_CR41","doi-asserted-by":"publisher","unstructured":"Patschan D, Schwarze K, Henze E, Patschan S, M\u00fcller GA. Am J Physiol Renal Physiol. 2016 Jan 20:ajprenal.00306.2015. doi:\n                    10.1152\/ajprenal.00306.2015\n                    \n                  . [Epub ahead of print].","DOI":"10.1152\/ajprenal.00306.2015"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1197-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1197-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T22:51:29Z","timestamp":1487717489000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1197-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1197-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"article-number":"339"}}